Related Experiment Video
Updated: Jul 11, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
The surgical treatment of end-stage heart failure
Aaron S Blom1, Michael A Acker
1University of Pennsylvania Medical Center, USA.
Insights
Cardiac failure is a leading cause of death. Aggressive surgical interventions like revascularization and ventricular remodeling can improve outcomes for patients with end-stage heart failure who have not responded to medication.
Area of Science:
- Cardiology
- Cardiac Surgery
- Heart Failure Management
Background:
- Cardiac failure is the primary cause of mortality in Western countries.
- Myocardial insult leads to ventricular remodeling, increased wall tension, and impaired cardiac function.
- Despite pharmacologic advancements, mortality rates for heart failure remain high.
Purpose of the Study:
- To review current surgical strategies for end-stage heart failure.
- To highlight the role of surgical interventions in halting or reversing ventricular remodeling.
- To emphasize an aggressive surgical approach for refractory heart failure.
Main Methods:
- Review of existing literature on surgical treatments for heart failure.
- Analysis of the impact of surgical interventions on ventricular remodeling and cardiac function.
- Discussion of emerging surgical therapies as alternatives to cardiac transplantation.
Main Results:
- Surgical therapies, once contraindicated, are now used to improve cardiac function in failing hearts.
- Surgical revascularization, mitral insufficiency correction, and ventricular remodeling can reverse adverse cardiac changes.
- Mechanical ventricular assistance offers a long-term solution for end-stage heart failure.
Conclusions:
- An aggressive surgical approach is warranted for heart failure patients unresponsive to pharmacologic therapy.
- Surgical interventions can significantly improve outcomes by addressing ventricular remodeling and cardiac dysfunction.
- Surgical options provide viable alternatives to cardiac transplantation for end-stage heart failure.
Abstract:
Cardiac failure remains the leading cause of death in the Western World today. After myocardial insult, as the heart remodels and dilates, an increase in wall tension occurs secondary to increased radius of curvature, leading to increased myocardial oxygen consumption, decreased subendocardial blood flow, impaired energetics, and increased arrhythmias. Poor prognosis directly correlates with the degree of remodeling. Despite improvements in left ventricular function and long-term outcomes seen with pharmacologic therapy, the results remain far from perfect and the mortality continues to be high. The surgical armamentarium for treating end-stage heart failure is broad and new types of surgical treatments continue to emerge as alternatives to cardiac transplantation for the treatment of end-stage heart failure. Furthermore, surgical therapies that were once contraindicated for use in the failing heart are now being used to halt or reverse ventricular remodeling and improve cardiac function. Therefore, an aggressive approach to surgical revascularization, correction of mitral insufficiency, surgical reversal of left ventricular remodeling, and long-term use of mechanical ventricular assistance should be considered in any heart failure patient who has exhausted pharmacologic therapy.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy II: Dilated Cardiomyopathy